Yoga for Youth With IBD: a Pilot Feasibility Study

Stanford University9 enrolled

Overview

An 8-week yoga intervention to determine the feasibility and acceptability of yoga as a supplemental therapy in the management of inflammatory bowel disease in the adolescent population.

Youth with IBD experience abdominal pain, diarrhea, weight loss, and psychological suffering related to their disease process. While many biologic and non-biologic therapies are available to target the inflammatory component of IBD, youth with IBD could benefit from a more holistic therapy that addresses psychological wellness, which has been shown, in turn, to reduce disease burden. It is known that stress (multiple varieties) leads to IBD flares. It is also known that mind-body intervention reduces stress. The mind-gut connection is widely discussed in medical circles, however, current therapies have not capitalized on it. The investigators would like to know if an easily accessible mind-body intervention (yoga) can improve wellness, lower stress levels, and reduce intestinal inflammation in youth with IBD. The study will be an 8-week feasibility pilot. Participants will be asked to participate in online yoga videos and in-studio yoga sessions. Participants will be asked to complete multiple surveys throughout the intervention and continue receiving standard care from their primary gastroenterology team.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Inflammatory Bowel Diseases Yoga Adolescents Crohn Disease Ulcerative Colitis

Interventions

YogaBEHAVIORAL

Yoga for 30 minutes three times weekly for 8 weeks in addition to three, 1-hour in-studio yoga sessions.

Eligibility

Sex: ALLMin age: 10 YearsMax age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 10-21 * Diagnosis of Crohn's Disease or Ulcerative Colitis * Patient of a Stanford Children's Health or Stanford-affiliated Pediatric Gastroenterologist * Ability to attend in-person meetings/training Exclusion Criteria: * Initiation of biologic therapy in prior 3 months * Hospital admission in prior 2 months * Major surgery in prior 1 month * PUCAI/PCDAI \>65 * Current pregnancy * Severe developmental or intellectual disability * Non-english speaking * Not participating in another concurrent clinical trial

Locations (1)

Lucile Packard Children's Hospital

Palo Alto, California, United States

Outcomes

Primary Outcomes

Assessment of acceptability

Focus Group

Time frame: 1 hour focus group at conclusion of intervention.

Secondary Outcomes

Fecal Calprotectin

Stool biomarker that indicates intestinal inflammation

Time frame: 6 weeks (Prior to intervention; After conclusion of intervention)

Pediatric Ulcerative Colitis Activity Index

5 question assessment tool for disease tracking for patient's with ulcerative colitis

Time frame: 6 weeks (Prior to intervention; After conclusion of intervention)

PROMIS-37

NIH Pediatric Assessment Tool

Time frame: 6 weeks (Prior to intervention; After conclusion of intervention)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.